TRICYCLIC COMPOUND

摘要

It is intended to provide a novel compound that has an action of reducing triglyceride in the liver and an action of reducing blood sugar level by suppressing the expression of SREBP-1c and is useful as a preventive/therapeutic agent for diabetes, hyperlipidemia, fatty liver, obesity, impaired glucose tolerance, a diabetes complication (for example, nephropathy, neuropathy, retinopathy and the like), metabolic syndrome and syndrome X. The present invention is directed to a novel tricyclic compound represented by the following general formula (I) and having an action of suppressing the expression of SREBP-1c or a pharmaceutically acceptable salt thereof.